NIPT (Noninvasive Prenatal Testing)

This is a screening test done during pregnancy to check for certain genetic problems in the baby. It uses a small sample of the mother's blood. It doesn't require inserting anything into the baby or the mother. It looks for specific genetic conditions.

Procedure

What people who've had NIPT (Noninvasive Prenatal Testing) report

Every report comes from a Lived member, sent anonymously.

Have you had NIPT (Noninvasive Prenatal Testing) for Pregnancy?

NameHow it went

About NIPT (Noninvasive Prenatal Testing)

Who It's For

Noninvasive prenatal testing (NIPT), also called cell-free DNA screening, is a blood test during pregnancy that estimates the chance that the fetus has certain chromosome conditions. The pregnant person's blood carries small free-floating fragments of DNA, some released from the placenta, whose DNA usually matches the fetus. A laboratory counts these fragments. If more come from one chromosome than expected, the fetus has a higher chance of carrying an extra copy of it, which is called a trisomy. The standard test screens for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13), and most versions also check for extra or missing X and Y chromosomes. Because it reads the sex chromosomes, it can also report the likely sex of the fetus. Some laboratories offer expanded panels that look for small missing or duplicated pieces of chromosomes or for rarer trisomies. These are less established than the standard panel, and their results are harder to interpret. US obstetric guidance says every pregnant person, at any age, should be offered prenatal screening and diagnostic testing, and that each person may accept or decline it. The American College of Medical Genetics and Genomics recommends NIPT over older blood-and-ultrasound screening for single and twin pregnancies because it is more accurate. It is especially relevant for people aged 35 or older, those who have had a previous pregnancy with a chromosome condition, and those whose ultrasound or earlier screening raised a concern. NIPT is a screening test, not a diagnosis. Diagnostic tests examine cells from the placenta (chorionic villus sampling, or CVS) or from the fluid around the fetus (amniocentesis) and can give a definite answer, but they involve a needle into the uterus and a slight risk of miscarriage. Some people go straight to diagnostic testing, some choose screening first, and some choose neither. NIPT also does not screen for neural tube defects (problems in how the brain and spine form), heart defects or most other birth defects, so an ultrasound or a separate blood test is still offered for those.

Before the Procedure

NIPT can be done from 10 weeks of pregnancy until delivery. Before about 10 weeks, there is usually too little placental DNA in the blood for a reliable result. Tell the care team if you are carrying more than one fetus, because that affects how reliable the result is. The main preparation is a conversation rather than anything physical. It helps to know which conditions the chosen test covers, whether you want the fetal sex reported, and how you would use a higher-chance result: some people want a diagnostic test to plan ahead, and others would decline further testing. A genetic counselor or the prenatal care team can explain the options and what different results would mean before the sample is taken.

During the Procedure

The test is an ordinary blood draw. A health professional places a small needle in a vein in the arm and collects a small amount of blood, which usually takes less than five minutes and may cause a brief sting. No sedation or ultrasound is involved, and nothing enters the uterus. The laboratory separates the cell-free DNA, measures what share of it came from the placenta (the fetal fraction), and compares the amount of DNA from each chromosome with what is expected. A fetal fraction of about 4 percent or more is generally needed to report a result.

Recovery & Aftercare

There is no recovery period. Slight soreness or bruising where the needle went in may occur and usually fades quickly. Results generally take about a week, sometimes up to two, and go to the care team first. Most laboratories report each condition separately as lower chance (negative) or higher chance (positive). A negative result means the condition is unlikely, but it does not rule it out, and it says nothing about conditions the test does not cover. A positive result means the chance is raised, not that the fetus is affected. How often a positive result turns out to be correct depends on how common the condition is in people like you. In an example from the American College of Obstetricians and Gynecologists, about 83 of 100 positive Down syndrome results were confirmed in a higher-risk group, but only about 33 of 100 in a lower-risk group. For that reason, a positive result should be confirmed with CVS or amniocentesis before any decision is based on it, and it is reasonable to ask for genetic counseling to go through the numbers. Sometimes the laboratory cannot report a result, most often because there is too little placental DNA. This is more likely when testing is early or in people with higher body weight, and it can also occur when the fetus has a chromosome condition. A repeat sample may work, but the guidance is that a failed result deserves genetic counseling and the offer of an ultrasound and diagnostic testing.

Risks & Complications

The blood draw itself carries no physical risk to the fetus and very little risk to the pregnant person. The meaningful risks come from what the result can and cannot tell you. False positives and false negatives both happen. Accuracy is highest for Down syndrome, which the test detects in about 99 percent of affected pregnancies, and lower for other conditions and for expanded panels. It is also less accurate when the pregnancy has more than one fetus or when the fetal fraction is low. Because the DNA comes from the placenta, a result occasionally reflects a chromosome change limited to the placenta rather than the fetus. A positive result can also lead to diagnostic testing, which has its own slight risk of miscarriage, and waiting for results can be stressful. The sample also contains the pregnant person's own DNA, so the test can sometimes uncover a chromosome or genetic condition in the parent. Unusual or unreportable results have occasionally led to the discovery of cancer in the pregnant person. If a report says the findings may not come from the fetus, it is worth asking the care team what follow-up they advise.

Questions to Ask Your Doctor

  1. 1.Which conditions does the test you are offering cover, and is an expanded panel worth it for me?
  2. 2.Given my age and history, how likely is a positive result to be correct?
  3. 3.If the result shows a higher chance, would you suggest CVS or amniocentesis, and when could it be done?
  4. 4.Will I still have an ultrasound or blood test for neural tube and other birth defects?
  5. 5.Can I choose not to be told the fetal sex or certain other findings?

Last reviewed • Oct 2026

Educational content, not medical advice.